Essex Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,717
| Closed | -$6.56M | – | 327 |
|
|
2025
Q1 | $6.56M | Sell |
49,717
-7,198
| -13% | -$950K | 1.37% | 10 |
|
|
2024
Q4 | $4.75M | Sell |
56,915
-1,470
| -3% | -$123K | 0.85% | 32 |
|
|
2024
Q3 | $4.27M | Buy |
58,385
+26,937
| +86% | +$1.97M | 0.74% | 44 |
|
|
2024
Q2 | $2.15M | Buy |
31,448
+30,215
| +2,451% | +$2.07M | 0.4% | 100 |
|
|
2024
Q1 | $85.3K | Sell |
1,233
-496
| -29% | -$34.3K | 0.02% | 232 |
|
|
2023
Q4 | $124K | Sell |
1,729
-380
| -18% | -$27.2K | 0.02% | 235 |
|
|
2023
Q3 | $110K | Sell |
2,109
-20
| -0.9% | -$1.04K | 0.02% | 292 |
|
|
2023
Q2 | $135K | Hold |
2,129
| – | – | 0.02% | 291 |
|
|
2023
Q1 | $115K | Sell |
2,129
-26
| -1% | -$1.41K | 0.02% | 302 |
|
|
2022
Q4 | $114K | Buy |
+2,155
| New | +$114K | 0.02% | 297 |
|
|
2018
Q4 | – | Sell |
-33,384
| Closed | -$724K | – | 538 |
|
|
2018
Q3 | $724K | Buy |
33,384
+1,384
| +4% | +$30K | 0.09% | 267 |
|
|
2018
Q2 | $565K | Buy |
32,000
+4,557
| +17% | +$80.5K | 0.07% | 283 |
|
|
2018
Q1 | $578K | Buy |
+27,443
| New | +$578K | 0.08% | 258 |
|
|
2016
Q4 | – | Sell |
-84,488
| Closed | -$1.29M | – | 379 |
|
|
2016
Q3 | $1.29M | Buy |
84,488
+67,964
| +411% | +$1.04M | 0.21% | 119 |
|
|
2016
Q2 | $641K | Sell |
16,524
-1,933
| -10% | -$75K | 0.11% | 205 |
|
|
2016
Q1 | $513K | Buy |
+18,457
| New | +$513K | 0.09% | 222 |
|